Advances in bioreactor control for production of biotherapeutic products
Advanced control strategies are well established in chemical, pharmaceutical, and food
processing industries. Over the past decade, the application of these strategies is being …
processing industries. Over the past decade, the application of these strategies is being …
[HTML][HTML] Digitally enabled approaches for the scale up of mammalian cell bioreactors
MK Alavijeh, I Baker, YY Lee, SL Gras - Digital Chemical Engineering, 2022 - Elsevier
With recent advances in digitisation and big data analytics, more pharmaceutical firms are
adopting digital tools to achieve modernisation. The biological phenomena within …
adopting digital tools to achieve modernisation. The biological phenomena within …
Deep learning in preclinical antibody drug discovery and development
Y Zhou, Z Huang, W Li, J Wei, Q Jiang, W Yang… - Methods, 2023 - Elsevier
Antibody drugs have become a key part of biotherapeutics. Patients suffering from various
diseases have benefited from antibody therapies. However, its development process is …
diseases have benefited from antibody therapies. However, its development process is …
Impact of mAb aggregation on its biological activity: rituximab as a case study
R Bansal, R Dash, AS Rathore - Journal of Pharmaceutical Sciences, 2020 - Elsevier
Monoclonal antibody (mAb) products are presently the dominant class of therapeutic
proteins. When stressed, they are known to be prone to molecular instabilities like …
proteins. When stressed, they are known to be prone to molecular instabilities like …
[PDF][PDF] Digital Chemical Engineering
MK Alavijeh, I Baker, YY Lee, SL Gras - minerva-access.unimelb.edu.au
abstract With recent advances in digitisation and big data analytics, more pharmaceutical
firms are adopting digital tools to achieve modernisation. The biological phenomena within …
firms are adopting digital tools to achieve modernisation. The biological phenomena within …